Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11833210 ASH1L inhibitors and methods of treatment therewith

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jolanta Grembecka0

EunGi Kim0

Tomasz Cierpicki0

Hongzhi Miao0

Hao Li0

Trupta Purohit0

Szymon Klossowski0

Jing Deng0

Date of Patent

December 5, 2023

0

Patent Application Number

175041590

Date Filed

October 18, 2021

0

Patent Citations

US Patent 6946144 Transdermal delivery system

0

US Patent 6960563 Spontaneous emulsions containing cyclosporine

0

US Patent 7030242 Selective inhibition of aggrecanase in osteoarthritis treatment

0

US Patent 8314140 4-hydroxythiobenzamide derivatives of drugs

0

US Patent 7998966 Axl kinase inhibitors

0

US Patent 10632209 ASH1L inhibitors and methods of treatment therewith

0

US Patent 6923983 Transdermal delivery of hormones

0

US Patent 6929801 Transdermal delivery of antiparkinson agents

0

Patent Primary Examiner

Niloofar Rahmani

0

CPC Code

0

0

Patent abstract

Provided herein are small molecules that bind to ASH1L and inhibit ASH1L activity, and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11833210 ASH1L inhibitors and methods of treatment therewith

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool